Source: International Congress 2019 – Indoor and outdoor air quality considerations
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Iqbal (Peshawar, Pakistan), M. Yousaf (Peshawar, Pakistan), J. Alam (Peshawar, Pakistan), Z. Ullah (Peshawar, Pakistan). Diagnostic yield of combined epidemiological and radiological data in Malignant Pleural Mesothelioma: A Pilot Study. 4450

Member's Comments

No comment yet.

Related content which might interest you: Thoracoscopy: Outcomes in non-diagnostic procedures Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural mesothelioma: A retrospective analysis of 32 cases Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline Source: ERS Webinars 2019 - Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline Year: 2019 Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT) Source: International Congress 2018 – New methods for diagnosing and treating lung diseases Year: 2018 Malignant pleural mesothelioma: Current status and future projections in Turkey Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 The patient perspective of treatment for Malignant Pleural Effusion (MPE)- results of a pilot service-evaluation questionnaire. Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Technical limitation of semi-automated volumetric analysis using CT in patients with Malignant Pleural Mesothelioma Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant Mesothelioma: Place for thoracoscopy Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Malignant Mesothelioma: Place for thoracoscopy Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Description of free-flowing pleural effusions in medical reports after echographic assessment: A proposal of standardization Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Volume quantification of malignant pleural mesothelioma Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Malignant Mesothelioma: place for thoracoscopy Source: ERS Skills Course 2016 Year: 2016 The effect of co-cancer morbidity on mortality in subjects with malignant mesothelioma - a register based study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Diagnostic value of PET-CT in pleural diseases Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015